Company intelligence / Profile preview

StepWise Medical

Ownership: Private
Development stage: Other

Overview

StepWise Medical identifies and develops innovative medical devices and digital health solutions, primarily in ophthalmology. It has successfully spun out several companies addressing unmet needs such as dry eye disease with a proprietary tear duct occlusion kit that preserves natural tears and supports drug delivery. Its portfolio includes both hardware devices and AI-powered diagnostic platforms. Clinical validation is ongoing for some products; one device has been tested in over 70 patients with positive results[5][6].

Therapeutic areas: Ophthalmology
Modalities: DeviceSoftware (AI-driven, biomarker-based diagnostic software)
Industry: Implantable Medical Devices

Partnerships

CBCC Global Research (joint global collaboration on clinical research operations)

Beyond the preview

Go deeper on StepWise Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on StepWise Medical.

Explore the full profile